• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒患者院内转运用优先级:分诊工具的制定和前瞻性验证。

Priority in interhospital transfers of patients with severe COVID-19: development and prospective validation of a triage tool.

机构信息

Sistema d'Emergències Mèdiques de Catalunya, España. Grupo RINVEMER. Red de Investigación de Emergencias Prehospitalarias.

Servei d'Urgències Hospital Universitari de Bellvitge, Barcelona, España.

出版信息

Emergencias. 2022 Feb;34(1):29-37.

PMID:35103441
Abstract

OBJECTIVES

To develop and validate a triage scale (Spanish acronym, TIHCOVID) to assign priority by predicting critical events in patients with severe COVID-19 who are candidates for interhospital transfer.

MATERIAL AND METHODS

Prospective cohort study in 2 periods for internal (February-April 2020) and external (October-December 2020) validation. We included consecutive patients with severe COVID-19 who were transported by the emergency medical service of Catalonia. A risk model was developed to predict mortality based on variables recorded on first contact between the regional emergency coordination center and the transferring hospital. The model's performance was evaluated by means of calibration and discrimination, and the results for the first and second periods were compared.

RESULTS

Nine hundred patients were included, 450 in each period. In-hospital mortality was 33.8%. The 7 predictors included in the final model were age, comorbidity, need for prone positioning, renal insufficiency, use of high-flow nasal oxygen prior to mechanical ventilation, and a ratio of PaO2 to inspired oxygen fraction of less than 50. The performance of the model was good (Brier score, 0.172), and calibration and discrimination were consistent. We found no significant differences between the internal and external validation steps with respect to either the calibration slopes (0.92 [95% CI, 0.91-0.93] vs 1.12 [95% CI, 0.6-1.17], respectively; P = .150) or discrimination (area under the curve, 0.81 [95% CI, 0.75-0.84] vs 0.85 [95% CI, 0.81-0.89]; P = .121).

CONCLUSION

The TIHCOVID tool may be useful for triage when assigning priority for patients with severe COVID-19 who require transfer between hospitals.

摘要

目的

开发并验证一个分诊量表(西班牙语首字母缩写 TIHCOVID),通过预测因严重 COVID-19 而需要院内转院的患者的危急事件,为患者分配优先级。

材料和方法

这是一项前瞻性队列研究,分为两个时期进行,内部验证期为 2020 年 2 月至 4 月,外部验证期为 2020 年 10 月至 12 月。我们纳入了由加泰罗尼亚紧急医疗服务转运的连续严重 COVID-19 患者。基于区域紧急协调中心与转运医院首次联系时记录的变量,建立了一个预测死亡率的风险模型。通过校准和区分度评估模型的性能,并比较了第一和第二期的结果。

结果

共纳入 900 例患者,每期各 450 例。院内死亡率为 33.8%。最终模型纳入的 7 个预测因子包括年龄、合并症、需要俯卧位、肾功能不全、在机械通气前使用高流量鼻氧、以及 PaO2 与吸入氧分数比值<50。模型的性能良好(Brier 评分 0.172),校准和区分度一致。我们未发现内部和外部验证步骤在校准斜率(分别为 0.92 [95%CI,0.91-0.93]和 1.12 [95%CI,0.6-1.17])或区分度(曲线下面积,分别为 0.81 [95%CI,0.75-0.84]和 0.85 [95%CI,0.81-0.89])方面存在显著差异(P =.150)。

结论

TIHCOVID 工具可用于为需要院内转院的严重 COVID-19 患者分配优先级时进行分诊。

相似文献

1
Priority in interhospital transfers of patients with severe COVID-19: development and prospective validation of a triage tool.新冠病毒患者院内转运用优先级:分诊工具的制定和前瞻性验证。
Emergencias. 2022 Feb;34(1):29-37.
2
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
3
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
4
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
5
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
8
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
9
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.
10
Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.缺失数据的存在是否会影响 SORG 机器学习算法在脊柱转移瘤患者中的性能?开发一种互联网应用算法。
Clin Orthop Relat Res. 2024 Jan 1;482(1):143-157. doi: 10.1097/CORR.0000000000002706. Epub 2023 Jun 12.

引用本文的文献

1
A transfer triage tool for COVID-19 mass critical care surges.一种用于新冠疫情大规模重症护理高峰的转运分诊工具。
Sci Rep. 2025 Apr 5;15(1):11726. doi: 10.1038/s41598-025-95337-8.
2
Innovation through Artificial Intelligence in Triage Systems for Resource Optimization in Future Pandemics.通过人工智能优化分诊系统以在未来大流行中实现资源优化创新。
Biomimetics (Basel). 2024 Jul 18;9(7):440. doi: 10.3390/biomimetics9070440.
3
Therapeutic strategy in the transplanted patient.移植患者的治疗策略。
Rev Esp Quimioter. 2023 Nov;36 Suppl 1(Suppl 1):18-21. doi: 10.37201/req/s01.05.2023. Epub 2023 Nov 24.
4
[Revisit after discharge from the emergency department in a cohort of patients with COVID-19 pneumonia and analysis based on the healthcare resource used for follow-up. RESALSEVID study].[新型冠状病毒肺炎患者急诊科出院后复诊情况及基于随访所用医疗资源的分析。RESALSEVID研究]
J Healthc Qual Res. 2023 Jan-Feb;38(1):26-34. doi: 10.1016/j.jhqr.2022.05.007. Epub 2022 Jun 8.
5
COVID-19: Some unresolved issues.新型冠状病毒肺炎(COVID-19):一些未解决的问题。
Rev Esp Quimioter. 2022 Oct;35(5):421-434. doi: 10.37201/req/028.2022. Epub 2022 Apr 21.